Noxopharm soars after revealing prostate cancer breakthrough
SYDNEY: Biotech Noxopharm jumped as much as 7.6 per cent today after the cancer treatments
SYDNEY: Biotech Noxopharm jumped as much as 7.6 per cent today after the cancer treatments